fbpx

World Pharma News

11

Nov2019
Roche has discontinued a phase 2/3 trial of RG6206 after a futility analysis showed that the drug was ... Read More

11

Nov2019
Novo Nordisk A/S and UBE Industries Ltd. today announced that Novo Nordisk has obtained an exclusive worldwide licence ... Read More

11

Nov2019
Patients with severe opioid addiction are being given brain implants to help reduce their cravings, in the first ... Read More

11

Nov2019
Today the U.S. Food and Drug Administration granted approval to Reblozyl (luspatercept–aamt) for the treatment of anemia (lack ... Read More
Share this: